Studies on the gene expression of OSF-1 in osteoblasts derived from normal and osteoporosis patients.
正常和骨质疏松患者成骨细胞中 OSF-1 基因表达的研究。
基本信息
- 批准号:04836021
- 负责人:
- 金额:$ 1.41万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1992
- 资助国家:日本
- 起止时间:1992 至 1994
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
OSF-1 has the activities promoting the differentiation and cell growth on osteoblasts and neurite out growth on neurons. The amino acid sequences are highly conserved among mammals' (human, bovine, mouse, rat) OSF-1, so the functions are seemed to have important and fundamental rolls on the osteogenesis and the nerve development. To study the functions of OSF-1 on the metabolism of bone, the relationship between the osf-1 expression and osteoporosis was examined. The nucleotide sequence of osf-1 cDNA derived from human osteoblasts was cofirmed to identical to that expressed in brain tissues. Next, the amount of osf-1 expression was compared between osteoblasts derived from osteoporosis patients and from healthy individuals. As the results, the expression of type I collagen was somewhat high in osteoblasts derived from patients, but the osf-1 and osteopontine expression levels were almost the same with non-patients samples. Then transgenic mice which over express human osf-1 gene under the regulation of bone specific promoter was constructed. Until now the phenotype of the transgenic mice were normal comparing to the non-transgenic mice. We are planing to construct a mice which defect the osf-1 gene expression by disruption of the gene by the targeting method.We also focused on the fact that osf-1 is highly expressed during development. Other osteo specific factors such as BMPs are functioned in both osteogenesis and embryo genesis. To investigated the osf-1 function on the embryo genesis we isolated Xenopus laevis osf-1 homologue cDNA clones. The expression of x-osf-1 was increased at the tail-bud stage and the expression site was limited at the hind brain region. So osf-1 was thought to be a regulatory factor to develop a specialized tissues rather than the funcamental level such as BMPs which concerning in the determination of the axis of the embryo.
OSF-1具有促进成骨细胞的分化和细胞生长以及促进神经元突起生长的活性。哺乳动物(人、牛、小鼠、大鼠)OSF-1的氨基酸序列高度保守,其功能在骨形成和神经发育中具有重要的基础作用。为探讨骨形成因子-1(OSF-1)在骨代谢中的作用,本研究检测了osf-1的表达与骨质疏松症的关系。人成骨细胞osf-1cDNA的核苷酸序列与脑组织中表达的osf-1cDNA的核苷酸序列完全一致。接着,比较来自骨质疏松症患者和健康人的成骨细胞的osf-1表达量。结果显示,在患者来源的成骨细胞中,I型胶原的表达略高,但osf-1和骨桥蛋白的表达水平与非患者样品几乎相同。构建了骨特异性启动子调控下过表达人osf-1基因的转基因小鼠。到目前为止,转基因小鼠的表型与非转基因小鼠相比正常。我们计划通过基因打靶的方法破坏osf-1基因的表达,构建一个osf-1基因表达缺陷的小鼠,并关注osf-1在发育过程中高表达的事实。其他骨特异性因子如BMP在骨发生和胚胎发生中起作用。为了研究osf-1在非洲爪蟾胚胎发生中的功能,我们分离了非洲爪蟾osf-1同源cDNA克隆。x-osf-1在尾芽期表达增强,表达部位仅限于后脑区。因此,osf-1被认为是一个特殊组织发育的调节因子,而不是像骨形成蛋白那样在功能水平上参与胚胎中轴的决定。
项目成果
期刊论文数量(36)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Katsura, M., et.al.: "Nicotine increases diazepam binding inhibitor (DBI) mRNA in primary cultured" Neuroscience Letters. 168, neurons.1-4 (1994)
Katsura, M. 等人:“尼古丁会增加原代培养物中地西泮结合抑制剂 (DBI) mRNA”《神经科学快报》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tamotsu Hashimoto-Gotoh: "Current Perspective on Molecular & Cellolar Oncolosy Volume1.PartA^<211>〜_<230> Unosual Sequene conservation in Intron-1 of c-H-ras Oncogene and Its effect on p21 Protein synthesis" JAI Press Ltd, 20 (1992)
Tamotsu Hashimoto-Gotoh:“分子和细胞肿瘤学卷1.PartA^<211>〜_<230> c-H-ras 癌基因内含子 1 中异常序列保守性及其对 p21 蛋白质合成的影响的当前观点” JAI Press Ltd,20 (1992)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Toba, M., Minowa: "Characterization of spontaneous elimination of streptomycin sensitivity gene on high copy number plasmids : Sms-enforcement cloning vectors with synthetic rpsL gene." Gene. 121. 25-33 (1992)
Toba, M., Minowa:“高拷贝数质粒上链霉素敏感性基因自发消除的特征:具有合成 rpsL 基因的 Sms 执行克隆载体。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tada, N.et.al.: "Isolation and characterization of a mouse Protein C cDNA." J.Biochem.111. 491-495 (1992)
Tada, N.et.al.:“小鼠 C 蛋白 cDNA 的分离和表征。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
T.Hashimoto-G et.al.: "Construction and characterization of new host-vector systems for the enforcement-cloning method." Gene. 137. 211-216 (1993)
T.Hashimoto-G 等人:“用于强制克隆方法的新宿主载体系统的构建和表征。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HASHIMOTO-GOTOH Tamotsu其他文献
HASHIMOTO-GOTOH Tamotsu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HASHIMOTO-GOTOH Tamotsu', 18)}}的其他基金
Development of selective culture and cell plantation systems for mouse osteoblasts over-expressing human osteoblast stimulating factor-1 (OSF1)
开发过表达人成骨细胞刺激因子-1 (OSF1) 的小鼠成骨细胞的选择性培养和细胞种植系统
- 批准号:
14571393 - 财政年份:2002
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigations of bones of transgenic mice over expressing human human osteob stimulating factor-1 (OSF-1).
对过度表达人骨刺激因子-1 (OSF-1) 的转基因小鼠骨骼的研究。
- 批准号:
11671447 - 财政年份:1999
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Virtual Mouse and Human Twins for optimising Treatments for Osteoporosis
虚拟小鼠和人类双胞胎用于优化骨质疏松症的治疗
- 批准号:
EP/Z000203/1 - 财政年份:2024
- 资助金额:
$ 1.41万 - 项目类别:
Research Grant
Optimizing osteoporosis diagnosis through opportunistic computed tomography: developing an implementation strategy for early detection and intervention.
通过机会性计算机断层扫描优化骨质疏松症诊断:制定早期检测和干预的实施策略。
- 批准号:
484646 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Fellowship Programs
Center of Research Translation on Osteoporosis Bone Anabolic Therapies
骨质疏松症骨合成代谢疗法研究转化中心
- 批准号:
10404412 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Optimizing Small Molecule Mechanomimetics to Treat Age-related Osteoporosis.
优化小分子力学模拟治疗与年龄相关的骨质疏松症。
- 批准号:
10807685 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Leveraging a large cohort of patients with a unique, frequent renal sodium phosphate cotransporter, SLC34A3, pathogenic variation to understand and treat osteoporosis and kidney stones
利用大量具有独特、频繁的肾磷酸钠协同转运蛋白 SLC34A3 和致病变异的患者来了解和治疗骨质疏松症和肾结石
- 批准号:
494218 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Operating Grants
Exploring therapeutic effects of anti-inflammatory and resolving factors in osteoporosis model mice
探讨抗炎和缓解因子对骨质疏松模型小鼠的治疗作用
- 批准号:
23K15705 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Earlier identification and enhanced characterisation/quantification of Osteoporosis and Rheumatoid Arthritis for Clinics/MIU/ED/CDCs [“DT-RHU”]
诊所/MIU/ED/CDC 的骨质疏松症和类风湿关节炎的早期识别和增强表征/量化 [âDT-RHUâ]
- 批准号:
10068051 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Collaborative R&D
Prevention of osteoporosis through early monitoring of multiple measures of bone health in one device
通过在一台设备中早期监测多种骨骼健康指标来预防骨质疏松症
- 批准号:
EP/X000958/1 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Research Grant
Functional analysis of bone macrophages that control bone metabolism for the development of therapeutic drugs for osteoporosis.
控制骨代谢的骨巨噬细胞的功能分析,用于开发骨质疏松症治疗药物。
- 批准号:
23H03025 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation of the pathogenesis of glucocorticoid-induced osteoporosis targeting newly identified circulating osteoclast precursor cells
针对新发现的循环破骨细胞前体细胞阐明糖皮质激素诱导的骨质疏松症的发病机制
- 批准号:
23K08707 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




